Federal award
BIOMERIEUX INC
FA282317F6006
Contract
Obligated and Ceiling
- Obligated (net)
- $117,656.00
- Ceiling (potential value, not spending)
- $134,464.00
- Current value
- $134,464.00
- Gross positive obligations
- $134,464.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- BIOMERIEUX INC · HCNVCMEG9NL6
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- BIOMERIEUX INC · HCNVCMEG9NL6
- Awarding agency
- Department of War · sub-agency 5700 · office FA2823
- Funding agency
- Department of War · sub-agency 5700
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- FA282317F6006
- Parent vehicle (IDV PIID)
- V797P7128A
- Award type code
- C
- Actions
- 7 · May 4, 2017 to Mar 20, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History7
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Mar 20, 2025 | FY2025 | P00006 | B | −$16,808.00 | — |
| May 9, 2022 | FY2022 | P00005 | B | $12,224.00 | — |
| Apr 22, 2021 | FY2021 | P00004 | G | $24,448.00 | — |
| Apr 24, 2020 | FY2020 | P00003 | G | $24,448.00 | — |
| May 8, 2019 | FY2019 | P00002 | G | $24,448.00 | — |
| Apr 16, 2018 | FY2018 | P00001 | G | $24,448.00 | — |
| May 4, 2017 | FY2017 | 0 | — | $24,448.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.